<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=348185225613720&amp;ev=PageView&amp;noscript=1">

GENEWIZ offers COVID-19 surveillance through sub-strain identification​

In response to emerging COVID-19 sub-strains, GENEWIZ has developed workflows specifically tailored for their identification. Mutations within the genome of sub-strains may result in differences in infectability, severity, and vaccine response, therefore characterizing and tracking them is essential for successful surveillance and prevention.

With our global presence, state-of-the-art facilities, and highly-qualified scientific team, we are well-equipped to support the scale and speed needed for your COVID-19 sequencing and surveillance initiatives. 

Why choose GENEWIZ?
  • State-of-the-art CAP/CLIA Laboratory with quality assurance oversight
  • Industry-Leading Turnaround Time with options for expedited sample processing & sequencing
  • Complete Solutions Workflow from nucleic acid extraction to data analysis
  • Dedicated Study Manager to facilitate project coordination and technical support
Contact us:
To speak with an expert or discuss your specific COVID-19 project, please fill out the following form:

For technical support questions, please contact our team of experts

877-GENEWIZ (436-3949), Ext. 1 | CLIA@genewiz.com